Clinical Trials
- Liver
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
- Ages18 years and older
- GenderBoth
- Date09/17/2017
- Lung Cancer
A Biomarker-directed Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy
- Date02/24/2020
- Brain and Other Nervous System Cancers, Pediatric Cancers
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Date03/18/2018
- Digestive System, Endocrine System
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
- Ages18 years - 85 years
- GenderBoth
- Date02/29/2020
- Phase 1 Cancers
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
- Date12/21/2020
- Phase 1 Cancers
A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1042 in Subjects With Malignant Solid Tumors
- Date10/07/2020
- Phase 1 Cancers
A First-In-Human, Phase 1/2 Study Of CFI-402411, a Hematopoietic Progenitor Kinase-1 (HPK1) Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
- Date04/12/2021
- Phase 1 Cancers
A First-in-human, Two-part Clinical Study to Assess the Safety, Tolerability and Activity of IV Doses of ICT01 as Monotherapy and in Combination With a Checkpoint Inhibitor, in Patients With Advanced-stage, Relapsed/Refractory Cancer
- Date02/21/2021
- Kidney & Urinary Tract
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients (STAGED-PKD)
- Ages18 years - 50 years
- GenderBoth
- Date04/17/2019
- Brain and Other Nervous System Cancers
A Multi-Center Phase 0/I Trial of Anti-TIGIT Antibody AB154 in Combination With Anti-PD-1 Antibody AB122 for Recurrent Glioblastoma
- Date04/20/2021